SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 24.76-2.7%2:37 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (5784)10/3/1998 11:37:00 PM
From: BigKNY3  Read Replies (1) of 9523
 
Big Pharma Report: October 3, 1998

Have PFun!

BigKNY3
_________________________________________
Big Pharma Review

- After 3 consecutive weekly gains, Big Pharma (-4.1%) followed the Dow (-3.0%) down. Two Pharmas reached all-time highs; PNU and JNJ. Every Big Pharma declined for perhaps the first time in 1998.

-After last week's 9.8% gain, PFE (-7.1%) suffered its largest weekly decline of the year. AHP (-11.2%) was this week's lurker ...on fears that its merger with Monsanto may face delays.

-In September, Big Pharma (+12.4%) tripled the Dow (+4.0%). Every Big Pharma was up led by AMGN (+24.1%), PNU (+20.4%), and SGP(+20.6%). PFE 's 13.7% increase was its largest monthly gain of the year.

-In the third quarter, Big Pharma was up 2.6% as compared to a 12.4% decline for the Dow. Big Pharma was one of only 14 of the 89 S&P industry sectors to post a quarterly gain...ranking 9th.

-LLY (+18.2%) was the quarterly leader. PFE declined 2.7% for the quarter breaking its 4 1/4 year streak of consecutive quarter to quarter increases.

-YTD, Big Pharma (+25.7%) continues to be the hot sector in a flat market (-1.6%). In the YTD race, WLA remains #1 (+75.7%), followed by SGP (+60.2%), AMGN (+38.2%), PNU (+32.9%) and PFE (+32.9%). BMY (+1.6%) and SBH (+1.2%) are battling for the caboose position.
_________________________________________________________

News You Can Use

John Manley Recommends PFE on "Wall Street Week"
news.com

PFE is #4 Holding in Janus 20
cbs.marketwatch.com

PFE Working on a Weight-Loss Drug
cbs.marketwatch.com

Delay in MTC/AHP Merger?
news.com

LLY/ICOS Testing Viagra Rival
cbs.marketwatch.com

Highlights form the 3/14/98 Big Pharma Report ICOS @ 13.38

<<This week's stock to watch: ICOS: Only Pharma with another PDE-V inhibitor in Phase II studies. Approval of Viagra should have a positive impact.>>

Men's Fitness Magazine Cover Story "Exposed! Viagra Myths
mensfitness.com

Dudley Danoff, MD (LA urologist) "There's no question that the magic blue pill is a phenomenon no urologist has ever seen before. Nothing has come down the urological turnpike to equal the attention, the excitement, the hope that Viagra has generated."

A Viagra Marriage
nypostonline.com

V News from New Zealand
press.co.nz

Viagra Lifts Irish Plant
news.com

Pentagon Puts Viagra Costs at $50M
cnn.com

The Antidepressant Market
scottlevin.com

PFE Comparative Charts

This Weeks' PFE Price Action versus the Dow. Note the similarity of the trends! Amazing!!!
quicken.com

PFE versus the Dow since the NDA submission for Viagra.
quicken.com

Analysts' Roll-Call
- Broker Ratings Summary quicken.com

-Norby Broker Reports
nordby.com

Market Environment Links

-Briefing.com Market Updates
briefing.com

-Briefing.com Market Environment
briefing.com

-The Federal Reserve Beige Book
bog.frb.fed.us

Investment Advice

8 easy ways to lose your shirt in stocks
usatoday.com

IBD: 26 Weeks to Investing
ibd.infostreet.com

PFE News Links
Yahoo Link quote.yahoo.com
Motley Fool Link quote.fool.com


ED News Links
Yahoo Link quote.yahoo.com
Motley Fool Link quote.fool.com
Yahoo Viagra Link headlines.yahoo.com
75
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext